Nengwen W. Ke

GuoXue Lane No.37
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications

Development and validation of an integrated imaging-pathology model for recurrence risk stratification in non-functional G1/G2 pancreatic neuroendocrine tumors: a multicenter study.

Development and validation of an integrated imaging-pathology model for recurrence risk stratification in non-functional G1/G2 pancreatic neuroendocrine tumors: a multicenter study.

Journal: European journal of radiology
Published: April 25, 2026

PEG-Dependent Tunable Degradation and Curcumin Release from Curcumin-Based Biomedical Polyurethanes.

PEG-Dependent Tunable Degradation and Curcumin Release from Curcumin-Based Biomedical Polyurethanes.

Journal: Biomolecules
Published: April 01, 2026

Blockage of cuproplasia inhibits pancreatic tumour-associated neutrophils infiltration through TRAF6/STAT3/CCL2 pathway.

Blockage of cuproplasia inhibits pancreatic tumour-associated neutrophils infiltration through TRAF6/STAT3/CCL2 pathway.

Journal: British journal of cancer
Published: July 08, 2025

Cost-effectiveness of open versus laparoscopic pancreaticoduodenectomy: a retrospective Markov model analysis from China.

Cost-effectiveness of open versus laparoscopic pancreaticoduodenectomy: a retrospective Markov model analysis from China.

Journal: Frontiers in oncology
Published: April 23, 2025

Risk Factor and Prediction Model for Malignant Transformation in Pancreatic Intraductal Papillary Mucinous Neoplasm.

Risk Factor and Prediction Model for Malignant Transformation in Pancreatic Intraductal Papillary Mucinous Neoplasm.

Journal: Cancer medicine
Published: April 01, 2025

64Cu Radiolabeled PDGFRβ-Targeting Affibody for PET Imaging in Pancreatic Cancer.

64Cu Radiolabeled PDGFRβ-Targeting Affibody for PET Imaging in Pancreatic Cancer.

Journal: Molecular pharmaceutics
Published: February 17, 2025

The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer.

The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer.

Journal: Cancer discovery
Published: November 21, 2024

A nomogram to preoperatively predict the aggressiveness of pancreatic neuroendocrine tumors based on CT features and 3D CT radiomic features.

A nomogram to preoperatively predict the aggressiveness of pancreatic neuroendocrine tumors based on CT features and 3D CT radiomic features.

Journal: Abdominal radiology (New York)
Published: October 07, 2024

Myosteatosis Is Associated With Overall Survival in Patients Receiving Pancreatectomy for Pancreatic Neuroendocrine Tumors.

Myosteatosis Is Associated With Overall Survival in Patients Receiving Pancreatectomy for Pancreatic Neuroendocrine Tumors.

Journal: ANZ journal of surgery
Published: September 18, 2024

Case report: Achieving significant tumor reduction in advanced pancreatic adenocarcinoma.

Case report: Achieving significant tumor reduction in advanced pancreatic adenocarcinoma.

Journal: Frontiers in oncology
Published: July 02, 2024

TIM-4 increases the proportion of CD4+CD25+FOXP3+ regulatory T cells in the pancreatic ductal adenocarcinoma microenvironment by inhibiting IL-6 secretion.

TIM-4 increases the proportion of CD4+CD25+FOXP3+ regulatory T cells in the pancreatic ductal adenocarcinoma microenvironment by inhibiting IL-6 secretion.

Journal: Cancer medicine
Published: February 03, 2024

Preoperative metabolic syndrome and prognosis after pancreatectomy for pancreatic cancer: A retrospective study.

Preoperative metabolic syndrome and prognosis after pancreatectomy for pancreatic cancer: A retrospective study.

Journal: World journal of surgery
Published: January 03, 2024
Showing 1-12 of 57

Last Updated: 09/26/2026